Childress Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $840K | Buy |
7,574
+1,914
| +34% | +$212K | 0.21% | 77 |
|
|
2025
Q1 | $634K | Buy |
5,660
+112
| +2% | +$12.5K | 0.18% | 80 |
|
|
2024
Q4 | $512K | Buy |
5,548
+79
| +1% | +$7.3K | 0.14% | 99 |
|
|
2024
Q3 | $459K | Sell |
5,469
-292
| -5% | -$24.5K | 0.12% | 122 |
|
|
2024
Q2 | $395K | Buy |
5,761
+1,507
| +35% | +$103K | 0.11% | 125 |
|
|
2024
Q1 | $312K | Sell |
4,254
-865
| -17% | -$63.4K | 0.09% | 145 |
|
|
2023
Q4 | $415K | Buy |
5,119
+1,077
| +27% | +$87.3K | 0.12% | 106 |
|
|
2023
Q3 | $303K | Buy |
+4,042
| New | +$303K | 0.1% | 122 |
|
|
2023
Q1 | – | Sell |
-5,155
| Closed | -$443K | – | 121 |
|
|
2022
Q4 | $443K | Sell |
5,155
-856
| -14% | -$73.5K | 0.15% | 103 |
|
|
2022
Q3 | $375K | Buy |
6,011
+1,940
| +48% | +$121K | 0.15% | 101 |
|
|
2022
Q2 | $252K | Buy |
4,071
+259
| +7% | +$16K | 0.1% | 136 |
|
|
2022
Q1 | $226K | Sell |
3,812
-1,089
| -22% | -$64.6K | 0.08% | 169 |
|
|
2021
Q4 | $356K | Sell |
4,901
-1,383
| -22% | -$100K | 0.15% | 116 |
|
|
2021
Q3 | $438K | Buy |
6,284
+2,943
| +88% | +$205K | 0.18% | 104 |
|
|
2021
Q2 | $230K | Sell |
3,341
-2,584
| -44% | -$178K | 0.1% | 145 |
|
|
2021
Q1 | $382K | Buy |
5,925
+1,668
| +39% | +$108K | 0.18% | 109 |
|
|
2020
Q4 | $248K | Buy |
+4,257
| New | +$248K | 0.14% | 82 |
|